NYU Grossman School of Medicine is a medical school of New York University, a private research university in New York City. It was founded in 1841 and is one of two medical schools of the university, with the other being the Long Island School of Medicine.

During the past decade, NYU Grossman School of Medicine conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NYU Grossman School of Medicine" #1 sponsor was "Titan Pharmaceuticals" with 3 trials, followed by "Adiso Therapeutics" with 1 trials sponsored, "Amgen" with 1 trials sponsored, "CareDx" with 1 trials sponsored and "Celyad Oncology SA" with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NYU Grossman School of Medicine" #1 collaborator was "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Applied Health Research Centre" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "GORTEC (Head and Neck Oncology and Radiotherapy Group)" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "NYU Grossman School of Medicine" are "Opioid Dependence" (2 trials), "ARDS" (1 trials), "Active Systemic Lupus Erythematosus" (1 trials), "Adenoma" (1 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "NYU Grossman School of Medicine" in a lesser frequency.

Most popular intervention types in "NYU Grossman School of Medicine" are "Drug" (12 trials), "Other" (6 trials), "Biological" (3 trials), "Device" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Probuphine (buprenorphine implant)" (2 trials), "Standard of Care" (2 trials), "ART24" (1 trials) and "Buprenorphine" (1 trials). Other intervention names were less common.

The vast majority of trials in "NYU Grossman School of Medicine" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "NYU Grossman School of Medicine". undefined are not yet recruiting, 8 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in NYU Grossman School of Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NYU Grossman School of Medicine, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".